Literature DB >> 6831292

Midazolam versus hydroxyzine as intramuscular premedicant.

R J Fragen, D I Funk, M J Avram, C Costello, K DeBruine.   

Abstract

A randomized, double-blind, placebo-controlled, study was carried out in which the effects of midazolam (0.08 mg.kg-1) and hydroxyzine (1.5 mg.kg-1), with or without atropine (0.4 mg) or hyoscine (0.4 mg) were compared as intramuscular premedicants. Midazolam produced quicker onset of action, greater anxiolysis for the first hour, greater amnesia, less local irritation and a higher overall rating by the patients. Drowsiness, while also greater after midazolam, was neither marked nor prolonged. Both drugs were given similar overall ratings by the anaesthetists who administered the anaesthetics. Neither drug produced systemic toxicity. Of the two drugs known to produce amnesia, midazolam had a more profound effect and had an earlier onset than hyoscine. Midazolam (0.08 mg.kg-1) shows good potential as an intramuscular premedicant, especially when anaesthetic induction occurs 30 to 60 minutes later. Hyoscine, but not atropine, enhances the effects of the sedative drugs.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6831292     DOI: 10.1007/bf03009342

Source DB:  PubMed          Journal:  Can Anaesth Soc J        ISSN: 0008-2856


  7 in total

1.  A water-soluble benzodiazepine, RO21-3981, for induction of anesthesia.

Authors:  R J Fragen; F Gahl; N Caldwell
Journal:  Anesthesiology       Date:  1978-07       Impact factor: 7.892

2.  Time course of antirecall effect of diazepam and lorazepam following oral administration.

Authors:  S P Kothary; A C Brown; U A Pandit; S K Samra; S K Pandit
Journal:  Anesthesiology       Date:  1981-12       Impact factor: 7.892

3.  Midazolam maleate induction in patients with ischaemic heart disease: haemodynamic observations.

Authors:  J G Reves; P N Samuelson; S Lewis
Journal:  Can Anaesth Soc J       Date:  1979-09

4.  [Relation between the clinical effect and the pharmacokinetics of midazolam following i.m. and i.v. administration/2nd comm.: Pharmacokinetical aspects (author's transl)].

Authors:  C Crevoisier; M Eckert; P Heizmann; D J Thurneysen; W H Ziegler
Journal:  Arzneimittelforschung       Date:  1981

5.  Comparison of two benzodiazepines for anaesthesia induction: midazolam and diazepam.

Authors:  J G Reves; G Corssen; C Holcomb
Journal:  Can Anaesth Soc J       Date:  1978-05

6.  Amnesic action of midazolam.

Authors:  J W Dundee; D B Wilson
Journal:  Anaesthesia       Date:  1980-05       Impact factor: 6.955

7.  RO 21-3981 for intravenous surgical premedication and induction of anesthesia.

Authors:  J T Conner; R L Katz; R R Pagano; C W Graham
Journal:  Anesth Analg       Date:  1978 Jan-Feb       Impact factor: 5.108

  7 in total
  7 in total

1.  Optimal administration time of intramuscular midazolam premedication.

Authors:  T Nishiyama; M Nagase; H Tamai; S Watanabe; T Iwasaki; A Hirasaki
Journal:  J Anesth       Date:  1995-03       Impact factor: 2.078

Review 2.  Anaesthetic premedication: aims, assessment and methods.

Authors:  T H Madej; R T Paasuke
Journal:  Can J Anaesth       Date:  1987-05       Impact factor: 5.063

3.  Density-modulated t's array, a new technique of processed electroencephalogram, for monitoring the effects of midazolam and nitrous oxide during spinal anesthesia.

Authors:  Hidekazu Katoh; Yoshio Kinefuchi; Mamoru Takiguchi; Yonosuke Yamasaki
Journal:  J Anesth       Date:  1994-12       Impact factor: 2.078

4.  Sedative and respiratory effects of intramuscular midazolam as a premedicant: Influence of gender.

Authors:  Toshiyuki Yano; Yoshikazu Haratake; Kenji Urata; Tohru Morioka
Journal:  J Anesth       Date:  1994-12       Impact factor: 2.078

5.  A pilot study of the efficacy of oral midazolam for sedation in pediatric dental patients.

Authors:  D A Haas; S A Nenniger; R Yacobi; J G Magathan; H A Grad; P E Copp; M D Charendoff
Journal:  Anesth Prog       Date:  1996

Review 6.  New intravenous anaesthetics and neuromuscular blocking drugs. A review of their properties and clinical use.

Authors:  C S Reilly; W S Nimmo
Journal:  Drugs       Date:  1987-07       Impact factor: 9.546

Review 7.  Midazolam. A review of its pharmacological properties and therapeutic use.

Authors:  J W Dundee; N J Halliday; K W Harper; R N Brogden
Journal:  Drugs       Date:  1984-12       Impact factor: 9.546

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.